Share. Connect. Create. Grow. · Socialiya
Oral cholesterol-lowering peptide approved after a decade in development

Merck & Co's Lipfendra (enlicitide) employs 13 enzymes in biocatalytic synthesis.

HEALTH NEWS August 06, 2026

Oral cholesterol-lowering peptide approved after a decade in development

Merck & Co's Lipfendra (enlicitide) employs 13 enzymes in biocatalytic synthesis.

11 views 0 likes 0 comments
Share:
Merck & Co's Lipfendra (enlicitide) employs 13 enzymes in biocatalytic synthesis.

Author: Chemistry World

Read Original Article

Related News

Latest News

Advertisement

Top Categories

Advertisement
Advertisement
Advertisement
Advertisement